Doctors: Cuba’s Coronavirus Miracle Cure ‘Harmful to

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone energy_wave #43535
561
Doctors: Cuba’s Coronavirus Miracle Cure
‘Harmful to the Lives of Thousands Worldwide’
< >

GettyImages-1206754199-200x150.png

The human rights NGO Cuban Prisoners Defenders published an article on Friday citing three Cuban medical researchers who concluded that the communist regime’s publicity campaign for Interferon alpha-2b, which it claims can cure Chinese coronavirus, is a “serious crime against world public health.”

“When the Government of Cuba assures that the Interferon developed in Cuba cures the coronavirus, it is committing a serious crime against world public health, since this drug not only lacks any scientific proof, but also where it has been tested has already given null results of encouragement,” the doctors concluded, urging the World Health Organization (W.H.O.) to formally condemn the Cuban Communist Party for urging off-label use of a dangerous drug when no clinical trials or scientific confirmations exist that it works.

Interferons are “involved in alerting the cellular immune system to viral infection of host cells. Interferons not only exhibit important antiviral effects but also exert a key influence on the quality of the cellular immune responses and amplify antigen presentation to specific T cells.” A study published in 2004 in the Journal of Clinical Virology found that interferon-beta can “strongly” block multiplication of the Sudden Acute Respiratory Syndrome (SARS) virus, a type of coronavirus, in human cells, but that interferon-alpha and interferon-gamma did not appear to have the same effect.

The Wuhan coronavirus is believed to be closely related to the SARS coronavirus. Cuba has spent months promoting a domestically developed interferon – interferon-alpha 2b – as a successful antiviral against the Wuhan virus, offering little to no evidence.

The doctors writing the Cuban Prisoners Defenders article warn that the use of interferon-alpha can cause severe side effects in patients while potentially having no effect on the Chinese coronavirus.

“Eminent Cuban doctors who have helped to prepare this report have witnessed its use in the elderly hospitalized with severe, community and hospital pneumonia – now classified as associated with health care – and have attested to Prisoners Defenders of the null reduction in mortality,” the report reads. “The existence of the corresponding clinical trials that justify their use is also unknown.”

The doctors note that the Cuban Communist Party’s argument in favor of the drug is simply that many who have taken it have also survived a Chinese coronavirus infection, which they conclude is insufficient evidence for global use of a drug with severe side effects.

If we consider that most patients develop mild or uncomplicated forms of the disease – some without symptoms – around approx. 14% can present severe forms with the need to receive oxygen, and another approx. 5% may require admission to Intensive Care units, how is it possible to ensure that the good evolution of most patients is due to the use of Heberferon [the brand name for Cuban interferon-alpha 2b] and not to the natural course of the disease?

If there are no minimally serious scientific protocols, with a control group, that is, patients who do not receive this drug to compare the evolution with those who do, and even other placebo control groups, the results are more than questionable and are not minimally serious.

It does not have the minimum necessary to be considered a scientific investigation.

As interferon-alpha has been used to treat hepatitis, the report quotes a hepatologist, Edward Mena, who states that their use results in a “very strong and difficult treatment.”

“The side effects are like you’re in chemical therapy. Patients have nausea, vomiting, body pain, anemia; platelets, white blood cells are lowered … it is a very strong and difficult treatment. The side effects are many,” Mena reportedly said.

The drug could “kill, rather than cure patients,” the doctors say.

Granma, the official publication of the Cuban Communist Party, proclaimed in March that the Cuban interferon was showing “effectiveness in treating patients with the new SARS Cov-2 coronavirus.” It thanked Fidel Castro – a lawyer, not a virologist, by trade – for the “visionary thinking” that created the interferon and claimed that Cuban and Chinese scientists came up with the treatment together. Granma had previously stated that Cuba was somehow developing 22 drugs to fight coronavirus, none of them accepted as treatments for the Wuhan virus.

Interferon-alpha 2b’s use against coronavirus in Wuhan, where the virus originated, has become part of the Cuban state media lore about its success. Yet the doctors writing for Cuban Prisoners Defenders say “experts [in Wuhan] come to tell us to ‘try if you want, but we have tried it and we have not obtained evidence of its benefits.'”

Cuban Prisoners Defenders concludes that the “reckless and dangerous” use and promotion of the drug is an attempt by the Cuban government to enrich itself even further off of its medical businesses, the largest of which is its $11-billion-a-year slave doctor trade.

“Cuba generates from 2 to 6 times the national income of tourism through the “rent” in a state of slavery of doctors that are sent to more than 60 countries in the world,” the doctors write.

While no drug has received universal approval as a safe treatment for coronavirus, the use of interferon-beta – not the interferon Cuba is promoting – is part of a drug cocktail undergoing trials under the W.H.O.’s auspices. Testing has reportedly begun on the use of interferon-beta along with two antivirals, Science magazine reported in March. One of the researchers the magazine quoted warned, “if it is given late in the disease it could easily lead to worse tissue damage instead of helping patients.”

Cuba has documented 923 cases of Chinese coronavirus as of Friday; 31 people have died, according to the communist government.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bamboo Unveils Tailored Home Insurance for Texans

Updated Category News Views 1

Adapt or Get Left Behind: The Texas Insurance Scene In a world where costs are ballooning and the pressure on the wallet grows heavier, here comes Bamboo Insurance swinging into Texas like a hopeful knight. This plucky insurer is rolling out the Texas Essential Homeowner Program, a highly adaptable, admitted policy that promises to put some power back into the hands of...

Continue Reading
Orbis Celebrates 20 Years of Eye Care in Macau

Updated Category News Views 2

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Continue Reading
LIV Golf's Big Play: Restructuring with Saudi PIF

Updated Category News Views 8

Trailblazing Change in the Golf World It's like watching a high-stakes game of chess where pieces are worth billions. White Knight Capital Corp. has thrown its hat into the ring with the Public Investment Fund of Saudi Arabia to overhaul LIV Golf Enterprises. This isn't your average Monday morning golf chat; it's full-on corporate drama with financial steroids. Debt Swap...

Continue Reading
Halloween 2026: Gemmy's Animatronics Add Thrills

Updated Category News Views 1

Halloween's New Twist with Gemmy's Animatronics Well, just when you thought Halloween couldn't get any more over the top, here comes Gemmy with their 3-foot tall animatronic characters ready to give your trick-or-treat scene that extra jolt. These aren't just any run-of-the-mill decorations. Nope, they come with a twist—an industrial-strength twist of scares and sweets...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
Hartford Students Get Boost from Hygiene Initiatives

Updated Category News Views 2

Beyond Backpacks: Essential Hygiene for Hartford Kids When September rolls around, it’s not just about those shiny new backpacks and unopened notebooks. In good ol’ Hartford, some students find themselves in need of basics that get overlooked—a stick of deodorant, a bar of soap, maybe some period products. Skimp on these, and all of a sudden, showing up for school...

Continue Reading
AI Platform Suno Sued for Exploiting Artists' Identities

Updated Category News Views 4

AI and the Music Business: A Legal Storm Brews Well, it looks like the music world’s hitting a rough patch with AI in the crosshairs. We've got Korein Tillery, a heavyweight in the legal arena, throwing down the gauntlet against Suno, an AI music-generation platform. Folks, welcome to the battleground where art meets tech and identity theft takes a whole new meaning....

Continue Reading
Chris Auffenberg Buick: 1.9% APR Drives New Deals

Updated Category News Views 3

New Financing Options in Carbondale In a world where financing a car sometimes feels like predicting the weather—unreliable and erratic—Chris Auffenberg Buick is turning the tables down in Carbondale with a refreshing approach. They're trotting out a 1.9% APR financing option for those Buick lovers who qualify, all through GM Financial. It's the kind of deal that...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 2

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading
Delisting Gray Wolf Sparks Heated Hunter Nation Debate

Updated Category News Views 2

Unraveling the Gray Wolf Controversy What are we looking at here—political maneuvering wrapped in a fur coat? Trump's executive order is making some calls I didn’t see coming. By pushing to delist the gray wolf from the Endangered Species Act (ESA), he's stirring up a mix of joy, outrage, and a boatload of debate about environmental ethics, conservation priorities,...

Continue Reading

Top 5 Most Recently Viewed Articles

UK Regulator Introduces New Probes into Tech Industry Practices

Updated Category News Views 172

UK Regulator's Initiative Against Major Tech Firms The competition landscape in the UK is about to evolve significantly. The UK's anti-trust regulator has announced plans to initiate two investigations using its newly authorized powers to tackle the leading tech firms. This move aims to bolster investment, innovation, and growth within the digital market. Understanding...

Continue Reading
Jeff Bezos' Bold Move: Embracing Risk to Propel Amazon Prime

Updated Category News Views 574

Understanding the Origins of Amazon Prime Amazon.com, Inc.'s AMZN Prime membership program has transformed into one of the most popular loyalty initiatives in retail history. However, its inception was shrouded in uncertainty and skepticism from key stakeholders, including Jeff Bezos himself. The Innovative Concept Behind Amazon Prime During a 2018 dialogue, Bezos...

Continue Reading
Sinch's Tier One A2P SMS Ranking Shows Commitment to Excellence

Updated Category News Views 231

Sinch Achieves Top Tier A2P SMS Ranking Sinch has recently been recognized as a Tier One vendor in the A2P SMS market, showcasing its leadership in delivering high-quality messaging solutions that are secure and versatile across the globe. This outstanding achievement in the messaging space comes from a comprehensive evaluation by leading industry analysts at ROCCO....

Continue Reading
Lexington Partners Expands Global Operations with New Office

Updated Category News Views 136

Lexington Partners Expands Global Operations with New Office – Doug Bourne Appointed to Lead Office; Thomas Dunn Relocates from London – Lexington Partners, one of the largest managers of secondary private equity and co-investment funds, proudly announces the opening of its new office in Abu Dhabi. This new location marks a significant step in expanding the firm's...

Continue Reading
Join the Thrilling XJTLU Global Dream Chasers Competition

Updated Category News Views 220

Exciting Opportunity for Student Entrepreneurs Aspiring student entrepreneurs from around the globe are invited to take part in the fourth XJTLU Global Dream Chasers Entrepreneurial Competition, organized by Xi'an Jiaotong-Liverpool University. This fantastic opportunity encourages participants to showcase their innovative ideas and entrepreneurial spirit. The first round...

Continue Reading